Article
Driver mutations (JAK2V617F, MPLW515L/K or CALR), pentraxin-3 and C-reactive protein in essential thrombocythemia and polycythemia vera.
Journal of hematology & oncology - 22 Feb 2017
Lussana Federico, Carobbio Alessandra, Salmoiraghi Silvia, Guglielmelli Paola, Vannucchi Alessandro Maria, Bottazzi Barbara, Leone Roberto, Mantovani Alberto, Barbui Tiziano, Rambaldi Alessandro
Abstract excerpt
BACKGROUND: The driver mutations JAK2V617F, MPLW515L/K and CALR influence disease phenotype of myeloproliferative neoplasms (MPNs) and might sustain a condition of chronic inflammation. Pentraxin 3 (PTX3) and high-sensitivity C-reactive protein (hs-CRP) are inflammatory biomarkers potentially useful for refining prognostic classification of MPNs. METHODS: We evaluated 305 with essential thrombocythemia (ET) and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
